Cargando...
Immunotherapy: Who is Eligible?
Recurrent and/or metastatic head and neck cancer portends a poor prognosis with traditional treatments, but current immunotherapy with immune checkpoint inhibitors has the potential to improve these clinical outcomes. This review focuses on the major breakthroughs that have led to our current unders...
Guardado en:
| Publicado en: | Otolaryngol Clin North Am |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2017
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6282181/ https://ncbi.nlm.nih.gov/pubmed/28755708 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.otc.2017.04.006 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|